Ketogenic Dieting Clinical Trial
Official title:
Determining the Ergogenic Effects of Carb10™ Supplementation on Carbohydrate-Rich and Carbohydrate-Restricted Diets
The study will examine the performance and body composition effects of ketogenic vs carbohydrate-based diets, determine the carbohydrate tolerance ("carbohydrate threshold") for active individuals on a ketogenic diet, and then, reexamine the performance and body composition effects when the diets are modified with supplemental carbohydrate up to the newly defined "ketogenic threshold."
Participants will be recruited from TWU and the Denton area and grouped in a semi-randomized
fashion that considers dietary preferences. They will then undergo baseline testing, begin
the diet and training interventions, followed by post-testing (phase 1) and a carbohydrate
titration period in the ketogenic diet group (phase 2). In the following academic semester,
the training intervention will be repeated with an adjusted dietary carbohydrate level,
delivered as a pre-workout supplement, corresponding to Phase 2 (Phase 3).
Phase 1 will consist of diets at an energy level estimated by the Mifflin St. Jeor equation
adjusted by 1.625 for exercise. The exercise intervention will be a supervised, periodized
(daily undulating), 9-week concurrent resistance (3 days/week) and cardiovascular (2
days/week) exercise program designed to improve body composition and performance variables.
During phase 2, the ketogenic diet participants will continue exercising with the same
program while consuming incrementally greater quantities of carbohydrate pre-workout until
the state of ketosis is lost. Phase 3 will be identical to Phase 1, but diets will be
modified to include more carbohydrate. As of completing Phase 2, this amount has been
determined to be 20g of Carb10 (pea starch).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Completed |
NCT03141008 -
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
|
||
Terminated |
NCT03790436 -
Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet
|
N/A | |
Not yet recruiting |
NCT06013397 -
Effectiveness of Ketogenic Diet in MELAS Syndrome
|
N/A | |
Recruiting |
NCT05689580 -
The Influence of Ketogenic Diet on Lupus Nephritis Patients' Immunity
|
N/A | |
Recruiting |
NCT04492228 -
Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome
|
N/A | |
Completed |
NCT05603689 -
Effect of Isocaloric Ketogenic Diet on Physical Performance at High Altitude
|
N/A | |
Completed |
NCT04744558 -
Low Carbohydrate High Fat Ketogenic vs. Non-ketogenic Diet
|
N/A | |
Completed |
NCT04108819 -
Ketogenic Diet for Obesity Hypoventilation Syndrome
|
N/A | |
Completed |
NCT04130724 -
Characterization of a Portable Solid-State Breath Acetone Testing Device for Real-Time Ketosis Status
|
||
Enrolling by invitation |
NCT05049954 -
Weight Loss for a Healthier You Programme
|
N/A | |
Recruiting |
NCT03564002 -
Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity
|
||
Recruiting |
NCT05591508 -
Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus
|
N/A | |
Completed |
NCT04112862 -
Sodium Lactate Infusion in GLUT1DS Patients
|
Early Phase 1 | |
Recruiting |
NCT03991897 -
Ketogenic Diet: a Novel Metabolic Strategy to Treat Lymphedema Patients?
|
N/A | |
Withdrawn |
NCT03202108 -
Evaluation of Krio in Children and Adults With Epilepsy
|
N/A | |
Completed |
NCT05012748 -
The Effects of Ketogenic Diet on the Heart and Brain
|
N/A | |
Completed |
NCT03982602 -
Ketogenic Diet for Traumatic Brain Injury
|
Early Phase 1 | |
Recruiting |
NCT06022796 -
Weight Loss Interventions for Obesity
|
N/A | |
Completed |
NCT05219006 -
Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures
|
N/A |